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A B S T R A C T
The most important prognostic factor for the patients with breast cancer are metastases to axillary lymph nodes
(ALNs). Preoperative ultrasound (US) combined with fine needle aspiration biopsy (US-FNAB) has been proved to be the
most reliable method to detect nonpalpable axillary metastases in patients with breast cancer. Our study was aimed to ex-
amine the value of US contrast agent (CA) SonoVue in the US examination of the axilla for the detection of axillary
lymph node (ALN) metastases in breast cancer patients. Therefore, two studies were performed. The first study included
27/70 patients with breast cancer who had an indeterminate result of the standard US examination of the axilla
(L/T<1.2 or MCT >3 mm or predominantly non-hilar vessel signal) and underwent US examination with CA. In the
second study, 26 breast cancer patients underwent standard axillary US examination performed independently by two
skilled operators. The patients with indeterminate or malignant ALN underwent US- guided fine needle aspiration bi-
opsy (US-FNAB). For macrometastases, the sensitivity, specificity, NPV and PPV of US-FNAB were 91%, 93%, 100%
and 100%, respectively. The reproducibility of the standard US examination (the second study) was 85% (22/26 patients),
and for the metastases larger than 5 mm, it was 100%. Moreover, our second study proved that the same results as with
CA can be achieved by two skilled operators performing a standard US examination. The sensitivity of both operators
was 92%. In the case of metastases larger than 5 mm, the reproducibility was 100%. Micrometastases remain a problem
also in the hands of very experienced operators even if using CA.
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Introduction
The most important prognostic factor for the patients
with breast cancer are metastases to axillary lymph
nodes (ALNs)1. Over the last 15 years, sentinel lymph
node (SLN) biopsy has been used as an alternative to the
routine axillary lymph node dissection (ALND) as a stan-
dard method for staging the patients with breast can-
cer2,3. ALND is indicated only in the patients with meta-
static deposits in the SLN. This, however, resulted in a
high number of second operations in the patients with
metastatic deposits in the SLN. Thus, an additional reli-
able preoperative staging of the ALNs can identify the
patients who should directly undergo ALND, sparing
them the second surgical procedure. Preoperative ultra-
sound (US) combined with fine needle aspiration biopsy
(US-FNAB) emerged as the most reliable method to de-
tect nonpalpable axillary metastases in the patients with
breast cancer4,6–8. As demonstrated in our previous study,
it can spare approximately 20 percent of breast cancer
patients or almost half of patients with metastases in
ALNs one surgical procedures4. However, the sensitivity
and specificity of the procedure is operator and equip-
ment dependent4–6. Baseline gray-scale and color Dopp-
ler US examinations have limited accuracy in the charac-
terization of ALNs in breast cancer patients7,8, because
benign and malignant lesions may have similar echo pat-
terns and vascular architectures. Examination by apply-
ing a contrast agent (CA) together with the usage of con-
trast – specific USmodes is contrast enhanced US (CEUS)
which facilitates to overcome the limitations of baseline
gray – scale and color Doppler US examinations. CEUS
was proved to have an improved diagnostic performance
in different organs9–11. Sulfur hexafluoride–filled micro-
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bubble CA is a second generation of CA. This agent has a
strong and long nonlinear harmonic response when it is
insonated with low acoustic power10,11.
The aim of the first study was to examine the addi-
tional value of using CA SonoVue for the detection of
ALN metastases.
The aim of the second study was to find out the
reproducibility of the standard US examination of the
axilla when performed by different operators.
Materials and Methods
From September 2006 to January 2007, seventy con-
secutive female patients aged 26–73 (mean age was 55
years) with histologically proved breast cancer and non-
palpable ALNs underwent standard preoperative US ex-
amination of the axilla. In both studies, US machine
(Aplio HV, Toshiba, Otawara, Japan) with a 7–12 MHz
38-mm linear transducer was used.
On gray-scale US, the size of each ALN visible by US
was measured by using the longitudinal (L) and trans-
verse (T) axis dimensions to obtain longitudinal-trans-
verse axis ratio (L/T). If central echoic hilus was de-
tected, the maximum cortex thickness (MCT) of lymph
node was measured.
The tumoral vessels were imaged by color Doppler US
using slow-flow settings (pulse repetition frequencies of
800–1,500 Hz, wall filters of 40–50 Hz and high levels of
color vs. echo priority and color persistence) for optimal
visualization of slow blood flows. For each ALN, the dis-
tribution of vessels was defined as hilar (central, benign)
and nonhilar (peripheral or mixed or malignant).
According to literature4, malignant ALNs were de-
fined as follows: L/T <1.2 and MCT >3 mm and predom-
inantly nonhilar vessel signal (Figure 1); in those, US-
-FNAB with a 21–G needle was performed. Benign ALNs
had L/T >1.2 and MCT <3 mm and predominantly hilar
vessel signal. If ALNs met only one criteria of malig-
nancy, the results obtained by baseline gray-scale and
color Dopler US examination were considered as indeter-
minate (Figure 2).
The first study was performed on 27 patients with in-
determinate result of CEUS. Before CA (SonoVue (Brac-
co, Milan, Italy) injection, a technique of low mechanical
index was applied to observe non linear harmonic an-
swer. After the preparation of CA (sulfur hexafluoride)
by shaking 2.4 mL (5 mg/mL) of it, CA was injected by a
21-G needle for 5–10 seconds, followed by 10-mL normal
saline flush. Microbubbles were observed for 200 sec-
onds. All patients received only one bolus. When more
than one ALNs were considered indeterminate on previ-
ous baseline gray-scale and color Doppler US, only the
largest ALN was examined by CEUS.
Malignant CEUS characteristics were nonenhanced
ALNs or parts of it because of deposits (Figure 3).
In all patients with malignant CEUS characteristics
additional US–FNAB of non enhanced part of lymph
node was performed.
In the second study aimed to test the interobserver
reproducibility from February 2007 to April 2007 addi-
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Fig. 1. USmalignant ALNwith peripheral type of vascularisation.
Fig. 2. US indeterminate ALN.
Fig. 3. US malignant ALN on CEUS.
tional 26 consecutive patients aged 31–73 (mean age was
52 years) with histologically proven breast cancer and
nonpalpable ALNs underwent standard axillary US ex-
amination performed independently by two skilled oper-
ators. When the result of the US was considered by one
or both observers as indeterminate or malignant, FNAB
was performed.
Informed consent was obtained from the patients of
both studies after the nature of the procedure had been
explained to them.
The patients with cytologically proved malignant cells
proceeded directly to ALND without SNB.
US and US-FNAB results were compared with final
histopathological results of ALNs and the sensitivity,
specificity, PPV and NPV were calculated.
Results
The first study
Preoperative US revealed an indeterminate result in
27/70 patients who were all referred to CEUS. CEUS was
successfully performed in all 27 patients and revealed 10
positive and 17 negative results. FNAB confirmed ALN
metastases in 9/27 patients who all proceeded directly to
ALND. All others underwent SLN biopsy which revealed
ALN metastases in additional 4 patients, in three of
them only micrometastases (2 mm). The mean size of
metastases was 7 mm (range 1–15). The mean size of
breast cancer was 1.4 cm.
The results of CEUS examination and FNAB were
true positive in 9 patients who underwent ALND with-
out SLNB. In 14 patients, the results were true negative,
those women underwent SLNB. In four patients, the sec-
ond operation – ALND, was performed because of the
false negative results. In 3/4 patients with false negative
results of CEUS, micrometastases were proved only his-
tologically, in one patient, a metastasis measuring 7 mm
was overlooked. For macrometastases, the sensitivity of
examination was 91% and the specificity and NPV were
93% and 100%, respectively. When CEUS was used in
combination with US-FNAB, PPV rose to 100%.
The second study
Also in the second study, ALNs were detected by US
in the axillae. Of 26 patients, 12 patients who underwent
gray-scale and color Doppler US performed blindly by
two skilled operators, had metastases in ALNs proved by
histology. The mean size of metastases was 13 mm; the
size range 2–20 mm. The mean size of breast cancer was
1.9 cm.
Of those 12 patients with histologically proven meta-
stases in ALNs detected preoperatively (92% sensitivity),
11 underwent ALND immediately. In 4 of those patients,
only one ALN was affected. In 13 patients, the results of
preoperative standard US examination performed blindly
by two skilled operators, were true negative. US-FNAB
was performed in 13/26 patients, because of indetermi-
nate or malignant appearance of ALNs. In 11/13 pa-
tients, metastatic cells were proved, so those patients pro-
ceeded directly to ALND. In 2/13 patients, only inflamma-
tory cells were found; so, they proceeded to SNLB. One
was later referred to ALND because of a 6 mm large me-
tastasis. In other 13 patients, FNAB was done; because
US examination confirmed benign ALNs, they under-
went SNLB. The results of US examination and US-
-FNAB performed by two skilled operators were reproduc-
ible in 22/26 patients (85%). In four patients, the results
of US examinations were suspicious for the first operator
who performed US-FNAB and proved metastases in ALNs
only in two patients. The ALNs of the same four patients
were assessed by the second operator as benign; so FNAB
was not done. The first operator had 92% sensitivity,
100% specificity, 100% PPV and 93% NPV. For the sec-
ond, the sensitivity was only 75%. The metastases in
ALNs that were assessed differently by the two operators
were smaller than 5 mm. The reproducibility for larger
metastases was 100%.
Discussion
The major drawback of SLNB which successfully re-
placed ALND is the need for a second operation in case of
a positive result.
It is well established that the preoperative US to-
gether with US-FNAB can reduce the number of SLN
procedures. As we demonstrated in our previous study, it
can spare approximately 20 percent of breast cancer pa-
tients or almost half of patients with metastases in the
ALNs one surgical procedure4. In this study, we assessed
the possibility of further reducing the number of unnec-
essary second operation by increasing the sensitivity of
preoperative US by CEUS. During the past decade, a
number of US CA that consist of encapsulated gas micro-
bubbles have been developed to enhance the intensity of
US signal12–16. The first CA Albunex (Molecular Biosy-
stems, San Diego, Calif) was used in echocardiography.
The second CA, the galactose-based Levovist (Schering,
Berlin, Germany), which is now available in a number of
European countries, has been proved to enchance the US
signal intensity in the vessels throughout the body, but it
has a very short half-life. Sono Vue can circulate for sev-
eral minutes after intravenous injection; this allows suf-
ficient time to examine specific anatomic areas of interest.
However, to date, CA was used mostly in the examination
of the liver. To the best of our knowledge, CEUS of ALNs
in breast cancer patients have been described only in one
work17. There are many reasons for this: firstly, with the
application of CA, a non invasive US examination be-
comes invasive; it is more time consuming for the pa-
tients as well as operator and is also much more expen-
sive. The operator must be skilled in axillary US and CA
procedures. It should be taken into account that nonlin-
ear harmonic answer to CA response is higher in abdomi-
nal examinations because abdominal probes are more
suitable to accept such answers than linear probes17.
In our study, the preoperative CEUS in combination
with US-FNAB detected 9/13 ALN metastases. It proved
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to be a very sensitive method (93%) in the examination of
patients with macrometastases, but not of those with
micrometastases. So the added value of CEUS is at best
questionable since it is sensitive only in the detection of
macrometastases. In the group of patients with macro-
metastases, a standard preoperative axillary US exami-
nation itself has a sensitivity of more than 80%4.
In our previous study, performed on 165 patients, the
reported sensitivity was already 84%, specificity 91%,
PPV 97% and NPV 62%4. The reasons for lower sensitiv-
ity at that time were most probably less experiences and
older equipment (Power Vision 8000 model SSA-390 A;
Toshiba; Otawara, Japan). For superficial tissue, the spa-
tial resolution of high frequency probes is well known5,6.
In the present study, examinations were performed on a
new machine (Aplio HU 80, Toshiba, Otawara, Japan);
therefore, the visibility of ALNs increased from 54% (in
the previous study) to 100%, and consequently, the sensi-
tivity and NPV also rose to more than 90%.
Moreover, our second present study of the reprodu-
cibility of the preoperative US, proved that the same re-
sults as with CEUS can be achieved by two skilled opera-
tors performing a standard US examination. The sensitiv-
ity of both operators was 92% (11/12). Moreover, this was
in fact the sensitivity of one very experienced senior op-
erator. The other operator had a sensitivity of 75%. How-
ever, in the case of metastases larger than 5 mm, the
reproducibility was 100%. Micrometastases remain a prob-
lem even if dealt with by very experienced operators or
by additional CEUS examination as was also proved in
the study by Rizzato and Chersevani17. Unfortunately,
this is the case also in USPIO-enhanced MR examination
because of partial volume effect19. On the other hand
there are only about 10% of patients with micrometasta-
ses in ALNs, and the prognostic value of micrometasta-
ses is not known at the moment18.
In conclusions, it seems that standard preoperative
US examination of the axilla by an experienced operator
is a very sensitive method in breast cancer patients with
macrometastases in ALN. In this group of patients, which
represents the great majority of patients with early bre-
ast cancer, there is no added value of additional CEUS ex-
amination. In the minority of patients with micrometa-
stases neither of the two methods is sensitive at all.
The standard preoperative axillary US procedure is
reproducible in 85% of patients.
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ULOGA KONTRASTNOG POTPAZU[NOG ULTRAZVUKA KOD PACIJENTICA S RANIM
RAKOM DOJKE
S A @ E T A K
Najva`niji prognosti~ki faktor za pacijentice s rakom dojke su metastaze na potpazu{nim limfnim ~vorovima (ALN).
Predoperativni ultrazvuk (US) u kombinaciji sa biopsijom uz pomo} citolo{ke punkcije (US-FNAB) pokazao se kao
najpouzdanija metoda otkrivanja neopipljivih potpazu{nih metastaza u pacijentica s rakom dojke. Cilj na{e studije je
bio ispitati vrijednost kontrastnog agenta ultrazvuka (CA) SonoVue tijekom ultrazvu~nog pregleda potpazu{nog pod-
ru~ja u cilju otkrivanja metastaza potpazu{nih limfnih ~vorova kod pacijentica s rakom dojke. Stoga smo proveli dva
istra`ivanja. Prvo istra`ivanje uklju~ivalo je 27/70 pacijentica s rakom dojke koje su imale neodre|ene rezultate nakon
standardnog ultrazvuka potpazu{ja (L/T<1,2 ili MCT>3 mm ili predominantni znak nehilarnih krvnih `ila) i koje su,
nakon toga, podvrgnute kontrastnom ultrazvuku. U drugom istra`ivanju, 26 pacijentica s rakom dojke podvrgnute su
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standardnom potpazu{nom ultrazvuku kojeg su izvela dva neovisna stru~na operatera. Pacijentice s neodre|enim ili
malignim potpazu~nim limfnim ~vorovima podvrgnute su ultrazvu~no vo|enom biopsijom citolo{kom punkcijom. U
slu~aju makrometastaza, osjetljivost operatera bila je 91%, specifi~nost 93%, NPV citolo{kom punkcijom 100% i PPV
citolo{kom punkcijom 100%. Produktivnost pregleda standardnim ultrazvukom (drugo istra`ivanje) bila je 85% (22/26
pacijenata), a za metastaze ve}e od 5 mm bila je 100%. [tovi{e, na{e drugo istra`ivanje dokazalo je da se mogu dobiti isti
rezultati sa dva stru~na operatera koji pregledavaju standardnim ultrazvukom kao i sa kontrastnim ultrazvukom. Osjet-
ljivost oba operatera bila je 92%. U slu~ajevima metastaza ve}ih od 5 mm, produktivnost je bila 100%. Mikrometastaze
ostaju problem i vrlo stru~nim operaterima, ~ak i kada koriste kontrastni ultrazvuk.
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